Clinical trial
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children…
NCT00459316 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00459316 |
|---|---|
| Title | Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth |
| Official title | Phase I/II Study of Safety and Immunogenicity of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in HIV-Infected Children and Youth And Open Label Immunogenicity Study of a Booster Dose of MCV4 in Previously Immunized HIV-Infected Children and Youth |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | International Maternal Pediatric Adolescent AIDS Clinical Trials Group |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections, Meningitis |
| Intervention type | Biological |
| Interventions | Quadrivalent meningococcal conjugate vaccine |
| Enrollment | 384 |
| Start date | Jun 1, 2007 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Apr 11, 2007 |
| Last update posted | Nov 3, 2021 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: